Related Experiment Videos
Hepatitis C infection: Updates on treatment guidelines
Renee Pozza1, Catherine Hill, Anna Marie Hefner
1Renee Pozza is an associate dean, professor, and NP at Azusa Pacific University and Southern California GI and Liver Centers, Azusa, Calif. Catherine Hill is an assistant professor at Azusa Pacific University, Azusa, Calif., and a hepatology NP at Southern California GI and Liver Centers, San Clemente, Calif. Anna Marie Hefner is an associate professor at Azusa Pacific University, Azusa, Calif., and an NP at Southern California GI and Liver Centers, Coronado, Calif. Beth Vawter is a family NP at Southern California Liver Centers, Riverside, Calif., and an educator at Azusa Pacific University, Azusa, Calif. Tarek Hassanein is a transplant hepatology outreach director at the University of Southern California, San Diego, and Medical Director of Southern California GI and Liver Centers, Coronado, Calif.
Hepatitis C virus (HCV) screening is vital due to its asymptomatic nature. New treatments offer high cure rates and improved safety for managing chronic liver disease.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis C virus (HCV) is a leading global cause of chronic liver disease.
- Asymptomatic infections often go undiagnosed, highlighting the need for screening at-risk populations.
- Effective screening is a critical public health priority for controlling HCV.
Purpose of the Study:
- To review current treatment guidelines for Hepatitis C virus infection.
- To outline the evaluation and management strategies for patients with HCV.
- To inform healthcare providers about advancements in HCV therapy.
Main Methods:
- Review of recent clinical studies and treatment guidelines for HCV.
- Analysis of efficacy and safety data for new antiviral medications.
- Synthesis of recommendations for patient evaluation and management.
Main Results:
- New medications demonstrate sustained virologic response rates exceeding 95%.
- Current therapies feature reduced adverse reactions and shorter treatment durations.
- Updated guidelines facilitate effective diagnosis and management of HCV.
Conclusions:
- Early diagnosis through screening is essential for effective Hepatitis C virus management.
- Modern antiviral treatments offer high cure rates with improved tolerability.
- Adherence to new guidelines can significantly improve patient outcomes in HCV care.